Tyra Biosciences Statistics
Total Valuation
TYRA has a market cap or net worth of $1.78 billion. The enterprise value is $1.53 billion.
Important Dates
The last earnings date was Monday, March 2, 2026, after market close.
| Earnings Date | Mar 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TYRA has 53.87 million shares outstanding. The number of shares has increased by 4.17% in one year.
| Current Share Class | 53.87M |
| Shares Outstanding | 53.87M |
| Shares Change (YoY) | +4.17% |
| Shares Change (QoQ) | +0.27% |
| Owned by Insiders (%) | 2.95% |
| Owned by Institutions (%) | 46.64% |
| Float | 19.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 6.84 |
| P/TBV Ratio | 6.86 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.67, with a Debt / Equity ratio of 0.02.
| Current Ratio | 14.67 |
| Quick Ratio | 14.25 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -39.83% and return on invested capital (ROIC) is -27.01%.
| Return on Equity (ROE) | -39.83% |
| Return on Assets (ROA) | -25.68% |
| Return on Invested Capital (ROIC) | -27.01% |
| Return on Capital Employed (ROCE) | -50.19% |
| Weighted Average Cost of Capital (WACC) | 10.07% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.00M |
| Employee Count | 60 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +181.90% in the last 52 weeks. The beta is 1.06, so TYRA's price volatility has been similar to the market average.
| Beta (5Y) | 1.06 |
| 52-Week Price Change | +181.90% |
| 50-Day Moving Average | 29.53 |
| 200-Day Moving Average | 17.28 |
| Relative Strength Index (RSI) | 59.06 |
| Average Volume (20 Days) | 816,158 |
Short Selling Information
The latest short interest is 5.14 million, so 9.55% of the outstanding shares have been sold short.
| Short Interest | 5.14M |
| Short Previous Month | 5.01M |
| Short % of Shares Out | 9.55% |
| Short % of Float | 27.04% |
| Short Ratio (days to cover) | 7.13 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -132.76M |
| Pretax Income | -119.95M |
| Net Income | -119.95M |
| EBITDA | -132.22M |
| EBIT | -132.76M |
| Earnings Per Share (EPS) | -$2.01 |
Full Income Statement Balance Sheet
The company has $256.00 million in cash and $5.81 million in debt, with a net cash position of $250.19 million or $4.64 per share.
| Cash & Cash Equivalents | 256.00M |
| Total Debt | 5.81M |
| Net Cash | 250.19M |
| Net Cash Per Share | $4.64 |
| Equity (Book Value) | 259.18M |
| Book Value Per Share | 4.83 |
| Working Capital | 247.36M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$95.14 million and capital expenditures -$141,000, giving a free cash flow of -$95.28 million.
| Operating Cash Flow | -95.14M |
| Capital Expenditures | -141,000 |
| Free Cash Flow | -95.28M |
| FCF Per Share | -$1.77 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TYRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.17% |
| Shareholder Yield | -4.17% |
| Earnings Yield | -6.75% |
| FCF Yield | -5.36% |
Analyst Forecast
The average price target for TYRA is $44.63, which is 35.20% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $44.63 |
| Price Target Difference | 35.20% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |